Clinical Trial Update: Use of QRX3 for Acute Tubular Necrosis Type of Renal Failure in Hospitalized Patients ( QRX-3 in ARF) [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 clinical trial update for QRX3 in acute kidney injury due to acute tubular necrosis in hospitalized patients; the study is currently not recruiting. T…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Injury
• Tubular Necrosis

Drugs mentioned

• QRX3 (QRX3)

Snippet

Sponsor: Ebima Clifford Okundaye | Conditions: Acute Renal Failure (ARF), Acute Tubular Necrosis | Phase 2, Phase 3 | Status: NOT_YET_RECRUITING